Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Aurobindo Pharma Ltd

NSE: AUROPHARMA · BSE: 524804 · Pharmaceuticals & Biotechnology · 63 announcements

Aurobindo Pharma Ltd news stories on ALFA NewsRead the news →
Share price
₹1,682.00
Market cap
₹97,691 Cr
Revenue (annual)
₹33,653 Cr
Net profit (annual)
₹3,505 Cr
P/E (TTM)
24.8×Sector 47.4×
Promoter holding
51.88%+0.06% QoQ
FII holding
16.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:26 IST BSE
Annual General Meeting

Aurobindo Pharma Annual General Meeting

Aurobindo Pharma held its 39th Annual General Meeting on August 27, 2026, to discuss financial statements, dividend, and director reappointments as per the AGM agenda.